
Sign up to save your podcasts
Or
Show Notes:
In this episode of the SMFM podcast, Dr. Marwan Maayeh is joined by Dr. Sura Alwan, an expert in teratology and birth defects epidemiology. Together, they explore the role of teratogens—agents that can cause birth abnormalities when exposed to the developing fetus. The conversation covers a wide range of topics, including the challenges MFM specialists face when counseling patients on medication use during pregnancy and the resources available for healthcare professionals and patients alike. Dr. Alwan highlights the work of OTIS (Organization of Teratology Information Specialists) and TERIS (Teratogen Information System) in providing evidence-based guidance on drug and environmental exposures in pregnancy. They also discuss the importance of research in identifying and managing teratogenic risks, the role of teratology databases, and combating misinformation in the field. Tune in for practical insights and resources on navigating these complex issues in MFM practice.
Additional Resources:
TERIS
OTIS/MotherToBaby
Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication Practice Guideline From the AAN, AES, and SMFM
smfmadvocates.org/positions
Transcript: Click here for the full transcript
4.7
2424 ratings
Show Notes:
In this episode of the SMFM podcast, Dr. Marwan Maayeh is joined by Dr. Sura Alwan, an expert in teratology and birth defects epidemiology. Together, they explore the role of teratogens—agents that can cause birth abnormalities when exposed to the developing fetus. The conversation covers a wide range of topics, including the challenges MFM specialists face when counseling patients on medication use during pregnancy and the resources available for healthcare professionals and patients alike. Dr. Alwan highlights the work of OTIS (Organization of Teratology Information Specialists) and TERIS (Teratogen Information System) in providing evidence-based guidance on drug and environmental exposures in pregnancy. They also discuss the importance of research in identifying and managing teratogenic risks, the role of teratology databases, and combating misinformation in the field. Tune in for practical insights and resources on navigating these complex issues in MFM practice.
Additional Resources:
TERIS
OTIS/MotherToBaby
Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication Practice Guideline From the AAN, AES, and SMFM
smfmadvocates.org/positions
Transcript: Click here for the full transcript
90,407 Listeners
61 Listeners
7,751 Listeners
43,685 Listeners
8,831 Listeners
12,614 Listeners
3,328 Listeners
111,096 Listeners
56,020 Listeners
429 Listeners
4,388 Listeners
201 Listeners
41,492 Listeners
368 Listeners
1,142 Listeners